nDatalyze Corp. announced that on December 5, 2023, NDAT signed a binding Clinical Study Agreement with Personalized Prescribing Inc., pursuant to a previously-announced Letter of Intent ("LOI") with the same company. The Corporation is now making changes to its biometric questionnaire to simplify the Clinical Study data collection process, which changes are expected to be complete before December 10, 2023, thus allowing the data collection to begin before year-end.

Because the DNA data already exists, the contemplated data collection is expected to happen in a short period of time whereafter the unique dataset is expected to be forwarded to Dr. Dale Stevens of York University's Faculty of Health, Department of Psychology where correlation, integration, and validation work is to be done pursuant to a previously-announced Mitacs project. The arrangement of the Mitacs project in ongoing.